| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |